Veradermics Inc (MANE) Price Prediction & ForecastMANEVeradermics Inc

Alphio's MANE stock price prediction model matches the current Veradermics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $129.32 (+1.74%). The 1-week path is $141.50 (+11.32%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

VeraDermics, Inc. (MANE) is a good buy right now due to its recent positive Phase 2 trial results for VDPHL01, which showed 88.9% of participants reporting improvement in hair loss. The stock is currently priced at $108.82, significantly below analyst targets of $160 from Citi and $170 from B. Riley, indicating substantial upside potential. Additionally, the stock has experienced a remarkable year-to-date change of +540.12%, reflecting strong investor interest and market confidence. However, the main risk is the negative net income trend, with a reported loss of $30,011,000 in Q1 2026, which investors should monitor closely.

Veradermics Inc (MANE) last closed at $127.11, gaining +3.95%. These facts feed the 1-day and 1-week MANE price prediction above.